Cost-Effectiveness Analysis of the High-Dose Trivalent Influenza Vaccine in the Elderly Population in Italy
ClinicoEconomics and Outcomes Research · 2026-05 · Volume 18 · 1-15
DOI: 10.2147/ceor.s588333 ↗Kurz gefasst
Fachartikel in der Zeitschrift ClinicoEconomics and Outcomes Research, 2026-05. Verfasst von Donatella Panatto und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy.
- Interuniversity Research Centre on Influenza and Other Transmissible Infections (CIRI-IT), Genoa, Italy.
- Department of Health Economics & Outcomes Research (HEOR), AdRes, Torino, Italy.
- Sanofi srl, Milano, Italy.
ORCID-Profile: Marco Bellone
Zitieren
APA
Panatto, D., Bellone, M., Castello, L., Zanetta, L., & Piccolo, A. (2026). Cost-Effectiveness Analysis of the High-Dose Trivalent Influenza Vaccine in the Elderly Population in Italy. ClinicoEconomics and Outcomes Research, Volume 18, 1-15. https://doi.org/10.2147/ceor.s588333
Vancouver
Panatto D, Bellone M, Castello L, Zanetta L, Piccolo A. Cost-Effectiveness Analysis of the High-Dose Trivalent Influenza Vaccine in the Elderly Population in Italy. ClinicoEconomics and Outcomes Research. 2026;Volume 18:1-15. doi:10.2147/ceor.s588333
BibTeX
@article{Panatto2026,
author = {Panatto, Donatella and Bellone, Marco and Castello, Luca and Zanetta, Laura and Piccolo, Alberto},
title = {Cost-Effectiveness Analysis of the High-Dose Trivalent Influenza Vaccine in the Elderly Population in Italy},
journal = {ClinicoEconomics and Outcomes Research},
year = {2026},
volume = {Volume 18},
pages = {1--15},
doi = {10.2147/ceor.s588333}
}
EUVIMED